Re: Cost-Effectiveness Analysis of Sacral Neuromodulation and Botulinum Toxin A Treatment for Patients With Idiopathic Overactive Bladder Editorial Comment

被引：0
|
作者：
Penson, David F.
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 06期
关键词：
D O I：
10.1016/j.juro.2012.02.2534
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2157 / 2158
页数：3
相关论文
共 50 条
  • [41] Effect of sacral neuromodulation on the spinal nociceptive reflex of patients with idiopathic overactive bladder
    Liao, Kwong-Kum
    Chen, Jen-Tse
    Lai, Kuan-Lin
    Liu, Chih-Yang
    Lin, Chia-Yi
    Lin, Yung-Yang
    Yu, Bill K. J.
    Wu, Zin-An
    NEUROMODULATION, 2008, 11 (01): : 50 - 55
  • [42] Cost-Effectiveness Analysis of Solifenacin Flexible Dosing in Patients With Overactive Bladder Symptoms in Four Nordic Countries Editorial Comment
    Milsom, I.
    Axelsen, S.
    Kulseng-Hansen, S.
    Mattiasson, A.
    Nilsson, C. G.
    Wickstrom, J.
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2841 - 2841
  • [43] SACRAL NERVE STIMULATION (SNS) FOR THE TREATMENT OF IDIOPATHIC REFRACTORY OVERACTIVE BLADDER: COST-EFFECTIVENESS COMPARED TO OPTIMAL MEDICAL THERAPY, BOTULINUM TOXIN A (BONT-A) AND PERCUTANEOUS TIBIAL NERVE STIMULATION (PTNS)
    Jenks, Julie
    Hamid, Rizwan
    Shah, Julian
    Greenwell, Tamsin
    Betts, Chris
    Walleser, Silke
    Hallas, Nataie
    Ockrim, Jeremy
    JOURNAL OF UROLOGY, 2013, 189 (04): : E560 - E560
  • [44] Sacral Nerve Stimulation (SNS) for the treatment of idiopathic refractory overactive bladder: cost-effectiveness compared to optimal medical therapy, botulinum toxin A (BoNT-A) and percutaneous tibial nerve stimulation (PTNS)
    Ockrim, J. L.
    Jenks, J.
    Shah, P. J. R.
    Greenwell, T. J.
    Wallesesr, S.
    Betts, C.
    Hallas, N.
    BJU INTERNATIONAL, 2013, 111 : 52 - 52
  • [45] Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patients
    Reekmans, Mathias
    Janssen, Janine M. W.
    Vrijens, Desiree M. J.
    Smits, Martijn A. C.
    van Koeveringe, Gommert A.
    Van Kerrebroeck, Philip E. V. A.
    NEUROUROLOGY AND URODYNAMICS, 2021, 40 (05) : 1120 - 1125
  • [46] COST-EFFECTIVENESS OF PHARMACOLOGIC TREATMENT OF OVERACTIVE BLADDER
    Malone, D. C.
    Armstrong, E. P.
    Bui, C.
    VALUE IN HEALTH, 2012, 15 (04) : A155 - A155
  • [47] Botulinum-A Toxin's efficacy in the treatment of idiopathic overactive bladder
    Moga, Marius Alexandru
    Banciu, Simona
    Dimienescu, Oana
    Bigiu, Nicusor-Florin
    Scarneciu, Ioan
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2015, 65 (01) : 76 - 80
  • [48] Combination of Sacral Neuromodulation and Tolterodine for Treatment of Idiopathic Overactive Bladder in Women: A Clinical Trial
    Tang, Hua
    Chen, Jian
    Wang, Yongfu
    Yu, Ting
    Guo, Changping
    Liao, Xiaoqi
    UROLOGY JOURNAL, 2014, 11 (04) : 1800 - 1805
  • [49] Effectiveness of Botulinum-A Toxin for the Treatment of Refractory Overactive Bladder in Children
    Marte, A.
    Borrelli, M.
    Sabatino, M. D.
    Balzo, B. D.
    Prezioso, M.
    Pintozzi, L.
    Nino, F.
    Parmeggiani, P.
    EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2010, 20 (03) : 153 - 157
  • [50] Cost-effectiveness analysis of sacral neuromodulation for faecal incontinence in the Netherlands
    van Wunnik, B. P. W.
    Visschers, R. G. J.
    van Asselt, A. D. I.
    Baeten, C. G. M. I.
    COLORECTAL DISEASE, 2012, 14 (12) : e807 - e814
12345